A Sontakke,
S Dighe, R Sharma, V Yadav… - International Journal of …, 2024 - Elsevier
Apremilast (APR) is a potent anti-psoriatic agent that inhibits the phosphodiesterase 4
enzyme. Due to the poor oral bioavailability and associated systemic side effects the clinical …